Eric Tam

3PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 18, 2025
EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors.

Oksana A Sergeeva, Guixian Jin, Mohosin Sarkar

|Oct 11, 2019
Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models.

Walid S Kamoun, Anne-Sophie Dugast, James J Suchy

|Oct 04, 2019
Antibody-mediated targeting of TNFR2 activates CD8<sup>+</sup> T cells in mice and promotes antitumor immunity.

Eric M Tam, Ross B Fulton, James F Sampson

Pageof 1